Charles River Laboratories | CRL - 股本和储备



金融业
股票价格
USD
资产
USD 7.53B
现金及等价物
USD 192.03M
销售成本
USD 655.29M
流动资产
USD 1.53B
流动负债
USD 1.13B
债务
USD 3.06B
EBIT
USD 119.89M
EBITDA
USD 272.95M
员工
18.6K
EPS每股收益
USD 3.02
股本和储备
USD 2.84B
销售毛利
USD 348.79M
债务利息支出
USD 30.34M
利息收入
USD -0.03
贷款资金
USD 2.62B
市值
USD 14.93B
净收入
USD -1.48M
营业费用
USD 2.84B
营业利润
USD 119.89M
普通股股本
USD 47.73M
PE价格收益
58.27
税前利润
USD -29.94M
销售收入
USD 1B
销售和管理费用
USD 228.9M
股票
USD 346.26M
贸易债权人
USD 140.98M
应收帐款人
USD 711.76M


股本和储备 更改 日
Agilent USD 7.36B 241M 2026-06
Align Technology USD 4.23B 83.03M 2026-06
Bio-Rad Laboratories USD 7.17B 322.6M 2026-06
Bruker USD 2.44B 67M 2026-06
Cardinal Health USD -2.88B 51M 2026-06
Charles River Laboratories USD 2.84B 59.06M 2026-06
Cigna USD 42.62B 410M 2026-06
Concord Medical Services Hldg CNY -2.1B 136.32M 2025-12
CVS Health USD 79.7B 2.25B 2026-06
Danaher USD 52.58B 368M 2026-06
Dentsply International USD 1.35B 33M 2026-06
Elevance Health USD 44.88B 981M 2026-06
Humana USD 19.21B 633M 2026-06
Illumina USD 2.84B 162M 2026-06
Incyte USD 6.34B 721.58M 2026-06
Intrexon USD 43.17M 75.33M 2024-06
IQVIA Holdings USD 6.17B 50M 2026-06
Laboratory Of America USD 8.61B 121.8M 2026-06
Lakefront Biotherapeutics EUR 3.26B 10.26M 2026-06
Lonza CHF 9.13B 513M 2025-12
McKesson USD -4.24B 2.07B 2026-06
Merck EUR 30.17B 430M 2026-06
Mettler Toledo International USD 12.82M 54.71M 2026-06
Novartis USD 41.95B 3.02B 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Quest Diagnostics USD 7.52B 150M 2026-06
Revvity USD 7.18B 67.62M 2026-03
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
United Therapeutics USD 6.4B 499.2M 2026-06
UnitedHealth USD 105.32B 3.62B 2026-03
Veradigm USD 1.02B 159.52M 2022-12
Waters USD 15.29B 12.73B 2026-03
West Pharmaceutical Services USD 2.99B 200K 2026-06